HR
Healthcare Realty Trust Incorporated
NYSEUSDEQUITY
Real Estate
DELAYED
Sell
-31/100
Last price
16.78
▼ 0.30 (1.76%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
17.11
Prev close
17.08
Day high
17.36
Day low
16.99
Volume
5.27M
Market cap
$5.91B
P/E (TTM)
—
52W range
16.31 – 22.04
Day trading desk
Gap from prior close
+0.18%
Prior close 17.08
VWAP
17.09
-1.81% from price
Relative volume
2.41×
Unusually busy
Session range
3.61%
16.75 – 17.35
Position in range
5%
Near session low
ATR (14D)
0.33
1.99% of price
Prior day high
17.62
PDH
Prior day low
17.02
PDL
Bid / ask spread
—
Quote not published
Session volume
9.14M
Avg 3.79M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-5.02%
-7.0%
1M
-10.88%
-12.0%
3M
-17.40%
-21.9%
6M
-3.62%
-21.8%
YTD
+0.53%
-13.7%
1Y
-4.70%
-21.1%
3Y
+11.59%
-70.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on HR open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
2.02M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 8, 26 | HULL ROBERT E Chief Operating Officer |
SELL | 21.00K | $401.31K | Direct |
| Jun 23, 26 | CALLAWAY AMANDA L Officer |
SELL | 25.77K | $524.87K | Direct |
| May 19, 26 | MOORE CONSTANCE B. Director |
STOCK | 6.68K | $135.00K | Direct |
| May 19, 26 | HENRY DAVID B Director |
STOCK | 6.68K | $135.00K | Direct |
| May 19, 26 | BOHJALIAN THOMAS N Director |
STOCK | 6.68K | $135.00K | Direct |
| May 19, 26 | RUFRANO GLENN J Director |
STOCK | 6.68K | $135.00K | Direct |
| May 19, 26 | WOOD DONALD C. Director |
STOCK | 6.68K | $135.00K | Direct |
| Mar 6, 26 | BOHJALIAN THOMAS N Director |
BUY | 10.00K | $180.90K | Direct |
| Mar 4, 26 | GABBAY DANIEL Chief Financial Officer |
BUY | 10 | $187 | Indirect |
| Feb 9, 26 | CALLAWAY AMANDA L Officer |
STOCK | 34.69K | $594.22K | Direct |
| Feb 9, 26 | HULL ROBERT E Chief Operating Officer |
STOCK | 33.86K | $580.00K | Direct |
| Feb 9, 26 | SCOTT PETER A Chief Executive Officer |
STOCK | 155.87K | $2.67M | Direct |
| Feb 9, 26 | CROWLEY RYAN E. Chief Investment Officer |
STOCK | 32.79K | $561.66K | Direct |
| Feb 9, 26 | LOOPE ANDREW E. General Counsel |
STOCK | 32.59K | $558.23K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BOHJALIAN THOMAS N |
Director | 92.20K | Stock Award(Grant) |
CALLAWAY AMANDA L |
Officer | 109.95K | Sale |
CROWLEY RYAN E. |
Chief Investment Officer | 199.24K | Stock Award(Grant) |
GABBAY DANIEL |
Chief Financial Officer | — | Purchase |
HELFRICH AUSTEN B. |
Chief Financial Officer | 99.14K | Stock Award(Grant) |
HULL ROBERT E |
Chief Operating Officer | 276.34K | Sale |
LOOPE ANDREW E. |
General Counsel | 184.49K | Stock Award(Grant) |
MOORE CONSTANCE B. |
Director | 91.22K | Stock Award(Grant) |
SCOTT PETER A |
Chief Executive Officer | 592.45K | Stock Award(Grant) |
WILSON JULIE F. |
Officer | 113.42K | Sale |
Fundamentals
Market cap$5.91B
Enterprise value$10.27B
Revenue (TTM)$1.15B
Gross profit$711.13M
EBITDA$701.34M
Net income$-89.65M
EPS (TTM)$-0.26
Free cash flow$493.02M
Total cash$24.67M
Total debt$4.40B
Book value / share$12.31
Shares outstanding342.72M
Float340.39M
Short % of float8.61%
Dividend yield5.63%
Beta (5Y)0.84
Valuation & profitability ratios
Trailing P/E—
Forward P/E243.43
PEG ratio8.82
Price / sales—
Price / book1.38
EV / revenue8.95
EV / EBITDA14.65
Gross margin61.95%
Operating margin14.71%
Profit margin-7.57%
Return on equity-1.92%
Return on assets0.86%
Debt / equity103.03
Current ratio0.34
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.15B | $1.25B | $1.33B | $918.93M | -7.8% |
| Operating revenue | $1.15B | $1.25B | $1.33B | $918.93M | -7.8% |
| Cost of revenue | $449.07M | $473.44M | $500.44M | $344.04M | -5.1% |
| Gross profit | $703.26M | $775.72M | $825.88M | $574.89M | -9.3% |
| Selling, general & admin | $72.57M | $83.12M | $58.41M | $52.73M | -12.7% |
| Total operating expense | $608.32M | $739.12M | $771.66M | $492.11M | -17.7% |
| Operating income | $94.94M | $36.60M | $54.22M | $82.78M | +159.4% |
| Net interest income | -$212.06M | -$241.90M | -$257.24M | -$148.24M | +12.3% |
| Pre-tax income | -$249.49M | -$663.90M | -$282.08M | $40.69M | +62.4% |
| Net income | -$246.07M | -$654.49M | -$278.26M | $40.90M | +62.4% |
| Net income to common | -$248.48M | -$660.40M | -$281.62M | $38.46M | +62.4% |
| Basic EPS | -0.71 | -1.81 | -0.74 | 0.15 | +60.8% |
| Diluted EPS | -0.71 | -1.81 | -0.74 | 0.15 | +60.8% |
| EBIT | -$42.18M | -$426.77M | -$23.50M | $188.93M | +90.1% |
| EBITDA | $568.99M | $295.55M | $752.39M | $666.71M | +92.5% |
| Basic shares | 349.80M | 365.55M | 378.93M | 252.36M | -4.3% |
| Diluted shares | 349.80M | 365.55M | 378.93M | 253.87M | -4.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $26.17M | $68.92M | $25.70M | $60.96M | — | -62.0% |
| Cash & short-term investments | $26.17M | $68.92M | $25.70M | $60.96M | — | -62.0% |
| Accounts receivable | $170.22M | $161.47M | $180.07M | $143.53M | — | +5.4% |
| Total current assets | $606.12M | $525.86M | $504.67M | $404.93M | — | +15.3% |
| Property, plant & equipment | $204.91M | $261.44M | $275.98M | $336.98M | — | -21.6% |
| Goodwill & intangibles | $20.42M | $33.24M | $318.26M | $305.04M | — | -38.6% |
| Total assets | $9.21B | $10.65B | $12.64B | $13.85B | — | -13.5% |
| Total current liabilities | $346.23M | $223.79M | $562.09M | $593.58M | — | +54.7% |
| Current debt | $120.00M | — | $349.80M | $349.11M | $210.00M | — |
| Long-term debt | $3.79B | $4.66B | $4.65B | $5.00B | — | -18.7% |
| Total debt | $4.15B | $4.96B | $5.30B | $5.70B | — | -16.4% |
| Total liabilities | $4.53B | $5.35B | $5.71B | $6.17B | — | -15.2% |
| Retained earnings | $128.24M | $374.31M | $1.03B | $1.31B | — | -65.7% |
| Shareholder equity | $4.62B | $5.23B | $6.82B | $7.57B | — | -11.8% |
| Working capital | $259.89M | $302.07M | -$57.42M | -$188.65M | — | -14.0% |
| Net tangible assets | $4.60B | $5.20B | $6.50B | $7.27B | — | -11.6% |
| Shares issued | 351.60M | 350.53M | 380.96M | 380.59M | — | +0.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$249.49M | -$663.90M | -$282.08M | $40.69M | +62.4% |
| Depreciation & amortisation | $611.17M | $722.32M | $775.89M | $477.78M | -15.4% |
| Stock-based compensation | $22.39M | $31.82M | $14.29M | $20.35M | -29.7% |
| Change in working capital | -$57.80M | -$25.86M | -$70.89M | -$32.81M | -123.5% |
| Operating cash flow | $457.10M | $501.62M | $499.82M | $272.75M | -8.9% |
| Capital expenditure | -$330.15M | -$248.98M | -$231.03M | -$163.54M | -32.6% |
| Investing cash flow | $710.83M | $900.92M | $349.14M | $1.63B | -21.1% |
| Share buybacks | -$4.01M | -$519.30M | -$2.30M | -$3.19M | +99.2% |
| Dividends paid | -$386.92M | -$457.85M | -$472.24M | -$1.41B | +15.5% |
| Financing cash flow | -$1.21B | -$1.36B | -$884.22M | -$1.86B | +10.9% |
| Free cash flow | $126.94M | $252.64M | $268.79M | $109.20M | -49.8% |
| End cash position | $26.17M | $68.92M | $25.70M | $60.96M | -62.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $281.85M | $278.99M | $258.09M | $297.76M | $297.50M | +1.0% |
| Operating revenue | $273.82M | $271.29M | $278.35M | $290.88M | $290.52M | +0.9% |
| Cost of revenue | $98.98M | $100.06M | $110.73M | $113.46M | $104.20M | -1.1% |
| Gross profit | $182.87M | $178.93M | $147.36M | $184.31M | $193.31M | +2.2% |
| Selling, general & admin | $14.36M | $17.34M | $13.79M | $21.77M | $23.48M | -17.2% |
| Total operating expense | $142.43M | $146.33M | $112.98M | $159.61M | $176.96M | -2.7% |
| Operating income | $40.44M | $32.60M | $34.38M | $24.70M | $16.35M | +24.0% |
| Net interest income | -$44.39M | -$43.49M | -$48.48M | -$55.42M | -$53.59M | -2.1% |
| Pre-tax income | -$43.95M | $21.00K | $14.59M | -$58.54M | -$160.14M | -209,409.5% |
| Net income | -$43.51M | -$56.00K | $14.39M | -$57.74M | -$157.85M | -77,603.6% |
| Net income to common | -$44.19M | -$714.00K | $13.93M | -$58.34M | -$159.03M | -6,089.6% |
| Basic EPS | -0.13 | 0.00 | 0.04 | -0.17 | -0.45 | — |
| Diluted EPS | -0.13 | 0.00 | 0.04 | -0.17 | -0.45 | — |
| EBIT | -$903.00K | $42.27M | $61.76M | -$4.38M | -$107.62M | -102.1% |
| EBITDA | $138.74M | $183.05M | $200.88M | $145.05M | $52.39M | -24.2% |
| Basic shares | 342.30M | 347.44M | 350.05M | 349.96M | 349.63M | -1.5% |
| Diluted shares | 342.30M | 347.44M | 350.05M | 349.96M | 349.63M | -1.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $18.99M | $26.23M | $26.17M | $43.34M | $25.51M | -27.6% |
| Cash & short-term investments | $18.99M | $26.23M | $26.17M | $43.34M | $25.51M | -27.6% |
| Accounts receivable | — | — | $170.22M | — | — | — |
| Total current assets | $114.88M | $149.65M | $606.12M | $648.09M | $383.71M | -23.2% |
| Property, plant & equipment | $201.92M | $202.71M | $204.91M | $209.29M | $243.91M | -0.4% |
| Goodwill & intangibles | — | — | $20.42M | — | — | — |
| Total assets | $9.00B | $9.15B | $9.21B | $9.86B | $10.24B | -1.6% |
| Total current liabilities | $449.65M | $457.66M | $346.23M | $392.59M | $519.35M | -1.8% |
| Current debt | $275.82M | $306.37M | $120.00M | $149.00M | $295.00M | -10.0% |
| Long-term debt | $3.89B | $3.80B | $3.79B | $4.34B | $4.40B | +2.5% |
| Total debt | $4.40B | $4.34B | $4.15B | $4.72B | $4.97B | +1.4% |
| Total liabilities | $4.73B | $4.65B | $4.53B | $5.11B | $5.35B | +1.7% |
| Retained earnings | $84.67M | $128.18M | $128.24M | $113.85M | $171.59M | -33.9% |
| Shareholder equity | $4.22B | $4.44B | $4.62B | $4.68B | $4.82B | -5.0% |
| Working capital | -$334.77M | -$308.01M | $259.89M | $255.50M | -$135.64M | -8.7% |
| Net tangible assets | $4.22B | $4.44B | $4.60B | $4.68B | $4.82B | -5.0% |
| Shares issued | 342.72M | 346.53M | 351.60M | 351.60M | 351.57M | -1.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$43.95M | $21.00K | $14.59M | -$58.54M | -$160.14M | -209,409.5% |
| Depreciation & amortisation | $139.64M | $140.79M | $139.12M | $149.43M | $160.01M | -0.8% |
| Stock-based compensation | $4.42M | $5.42M | $3.35M | $7.23M | $8.77M | -18.5% |
| Change in working capital | $10.61M | -$78.07M | $2.28M | -$14.29M | $32.38M | +113.6% |
| Operating cash flow | $142.19M | $52.88M | $132.34M | $113.75M | $163.22M | +168.9% |
| Capital expenditure | -$69.79M | -$61.15M | -$86.55M | -$88.82M | -$85.65M | -14.1% |
| Investing cash flow | -$7.02M | -$45.31M | $526.48M | $226.28M | -$3.10M | +84.5% |
| Share buybacks | -$75.73M | -$102.04M | -$379.00K | -$2.92M | -$498.00K | +25.8% |
| Dividends paid | -$82.25M | -$83.90M | -$84.39M | -$84.77M | -$108.95M | +2.0% |
| Financing cash flow | -$142.41M | -$7.50M | -$676.15M | -$322.19M | -$160.18M | -1,797.6% |
| Free cash flow | $72.39M | -$8.28M | $45.79M | $24.93M | $77.56M | +974.6% |
| End cash position | $18.99M | $26.23M | $26.17M | $43.34M | $25.51M | -27.6% |
Options analytics
Put / call volume
0.25
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
10.00
-41.3% from spot
ATM implied vol
6.3%
Nearest strike to spot
Skew (10% OTM)
+18.7%
Puts bid over calls
Call volume
8
Contracts, this expiry
Put volume
2
Contracts, this expiry
Heaviest call OI
10.00
0 contracts
Heaviest put OI
15.00
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.02 | -0.13 | -691.7% |
| Mar 2026 | -0.03 | 0.00 | +100.0% |
| Dec 2025 | -0.03 | -0.03 | -10.3% |
| Sep 2025 | -0.07 | -0.06 | +15.4% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.00 | 1 | $283.61M | -4.8% |
| Next quarter | 0.00 | 1 | $286.07M | -0.1% |
| Current year | -0.10 | 5 | $1.13B | -4.6% |
| Next year | 0.07 | 2 | $1.16B | +3.1% |
Analyst targets & ownership
Mean target$21.42
High target$24.00
Low target$18.00
Implied upside27.63%
Analyst count12
ConsensusNONE
Strong buy / Buy2 / 2
Hold9
Sell / Strong sell0 / 0
Held by insiders0.59%
Held by institutions115.34%
Institutions holding632
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
17.65
-4.94% from price
SMA 20
18.12
-5.96% from price
SMA 50
19.08
-10.70% from price
SMA 100
19.77
-15.12% from price
SMA 200
18.79
-9.30% from price
EMA 12
17.70
-5.22% from price
EMA 26
18.23
-7.97% from price
EMA 50
18.80
-10.73% from price
RSI (14)
17.1
Oversold
MACD (12,26,9)
-0.53
Hist -0.07
ATR (14)
0.33
1.96% of price
Realised vol 30D
12.3%
Annualised
Bollinger upper
19.26
20, 2σ
Bollinger lower
16.98
20, 2σ
50 / 200 cross
Golden
19.08 vs 18.79
Trend bias
Below 200
-9.30%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.12
Less volatile than market
Correlation to SPY
0.08
Largely independent
Realised vol 30D
12.3%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-22.1%
Peak to trough
Max drawdown 5Y
-61.6%
Peak to trough
ATR 14
0.33
1.96% of price
Beta (reported)
0.84
5Y monthly, from filing
Short interest
Shares short
16.11M
Prior 17.00M
Change vs prior
-5.2%
Shorts covering
% of float
8.61%
Normal
% of shares out
4.70%
Against total outstanding
Days to cover
5.3
Crowded exit
Float
340.39M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 1, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Aug 7, 26 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| Jul 31, 26 | Cantor Fitzgerald | MAINTAINED | Overweight | Overweight |
| Jul 9, 26 | JP Morgan | MAINTAINED | Neutral | Neutral |
| Jul 8, 26 | UBS | MAINTAINED | Neutral | Neutral |
| Jun 1, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| May 14, 26 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| May 13, 26 | UBS | MAINTAINED | Neutral | Neutral |
| May 8, 26 | Scotiabank | MAINTAINED | Sector Outperform | Sector Outperform |
| May 7, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| May 4, 26 | Cantor Fitzgerald | MAINTAINED | Overweight | Overweight |
| Apr 20, 26 | UBS | INITIATED | — | Neutral |
Dividends & splits
Forward rate$0.96 / yr
Forward yield5.63%
5-year avg yield5.66%
Payout ratio826.67%
Ex-dividend dateAug 11, 2026
Next pay dateAug 26, 2026
Last split1:2
Split dateDec 16, 2014
SEC filings
Offering Registrations
S-3 · 2026-07-31
Periodic Financial Reports
10-Q · 2026-07-30
Corporate Changes & Voting Matters
8-K · 2026-05-20
Corporate Changes & Voting Matters
8-K · 2026-05-19
Corporate Changes & Voting Matters
8-K · 2026-05-07
Corporate Changes & Voting Matters
8-K · 2026-05-05
Periodic Financial Reports
10-Q · 2026-05-01
Corporate Changes & Voting Matters
8-K · 2026-04-30
Headlines
Healthcare Realty Trust Announces Third Quarter Earnings Release Date and Conference Call
GlobeNewswire · 1d ago
Down 5.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Healthcare Realty Trust (HR)
Zacks · 16d ago
Healthcare Realty Trust Insider Sold Shares Worth $401,310, According to a Recent SEC Filing
MT Newswires · 28d ago
Healthcare Realty Trust (HR) Upgraded to Buy: What Does It Mean for the Stock?
Zacks · 30d ago
Why Healthcare Realty Trust (HR) Is Back In The Spotlight
Simply Wall St. · 35d ago
Bears are Losing Control Over Healthcare Realty Trust (HR), Here's Why It's a 'Buy' Now
Zacks · 36d ago
After Plunging 7.0% in 4 Weeks, Here's Why the Trend Might Reverse for Healthcare Realty Trust (HR)
Zacks · 55d ago
Healthcare Realty Trust (HR) Q2 2026 Earnings Call Transcript
Motley Fool · 60d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.